Evidence map›Paper›PMID 25307349›Full record

ArticleThe American journal of pathology2014

Accelerated partial hepatectomy-induced liver cell proliferation is associated with liver injury in Nur77 knockout mice.

Ying Hu, Qi Zhan, Hui-Xin Liu, Thinh Chau, Yuyuan Li, Yu-Jui Wan, Yu-Jui Yvonne Wan

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 20 citations in OpenAlex.

  1. The Role of Gut Microbiota in Liver Regeneration After Partial Hepatectomy: New Evidence From Animal and Human Studies.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. miR-22 gene therapy treats HCC by promoting anti-tumor immunity and enhancing metabolism.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

  • Erratum issued
  • Erratum issued
    Yuonne Wan, Yu-Jui [corrected to Wan, Yu-Jui]
5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ying HuDepartment of Medical Pathology and Laboratory Medicine, University of California, Davis Health Systems, Sacramento, California.
Qi ZhanDepartment of Gastroenterology and Hepatology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China; Guangzhou Digestive Disease Center, Guangzhou, China.
Hui-Xin LiuDepartment of Medical Pathology and Laboratory Medicine, University of California, Davis Health Systems, Sacramento, California.
Thinh ChauDepartment of Medical Pathology and Laboratory Medicine, University of California, Davis Health Systems, Sacramento, California.
Yuyuan LiDepartment of Gastroenterology and Hepatology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China; Guangzhou Digestive Disease Center, Guangzhou, China.
Yu-Jui WanDepartment of Medical Pathology and Laboratory Medicine, University of California, Davis Health Systems, Sacramento, California; Department of Gastroenterology and Hepatology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China; Guangzhou Digestive Disease Center, Guangzhou, China. Electronic address: yjywan@ucdavis.edu.
Yu-Jui Yvonne Wan
University of California Davis Medical Center · USGuangzhou First People's Hospital · CNGuangzhou Medical University · CN

Funding

Retinoids Xenobiotic Metabolism and Tumor PromotionR01CA053596 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI WAN, YU-JUI YVONNE · 1996 to 2014
$4.5M
Retinoic Acid, Its Receptors, and the LiverR01DK092100 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI WAN, YU-JUI YVONNE · 2011 to 2014
$1.4M
NCI NIH HHS R01 CA053596NCI NIH HHS R01CA053596NIDDK NIH HHS R01 DK092100NIDDK NIH HHS R01DK092100
6 · The paper itself

Abstract

Nur77, encoded by Nr4a1 (alias Nur77), plays roles in cell death, survival, and inflammation. To study the role of Nur77 in liver regeneration, wild-type (WT) and Nur77 knockout (KO) mice were subjected to standard two-thirds partial hepatectomy (PH). Nur77 mRNA and protein levels were markedly induced at 1 hour after PH in WT livers, coinciding with ERK1/2 activation. Surprisingly, Nur77 KO mice exhibited a higher liver-to-body weight ratio than WT mice at 24, 48, and 72 hours after PH. Nur77 KO livers exhibited increase in Ki-67-positive hepatocytes at 24 hours, with early induction of cell-cycle genes. Despite accelerated regeneration, Nur77 KO livers paradoxically incurred necrosis, hepatocyte apoptosis, elevated serum alanine aminotransferase activity, and Kupffer cell accumulation. Microarray analysis revealed up-regulation of genes modulating inflammation, cell proliferation, and apoptosis but down-regulation (due to Nur77 deficiency) of glucose and lipid homeostasis genes. Levels of proinflammatory cytokines IL-6, IL-12, IL-23, and CCL2 were increased and levels of anti-inflammatory IL-10 were decreased, compared with WT. Activated NF-κB and STAT3 and mRNA levels of target genes Myc and Bcl2l1 were elevated in Nur77 KO livers. Overall, Nur77 appears essential for regulating early signaling of liver regeneration by modulating cytokine-mediated inflammatory, apoptotic, and energy mobilization processes. The accelerated liver regeneration observed in Nur77 KO mice is likely due to a compensatory effect caused by injury.

Indexed as

Liver RegenerationAlanine TransaminaseAnimalsBody WeightCell ProliferationChemokine CCL2Extracellular Signal-Regulated MAP KinasesHepatectomyHepatocytesHomeostasisInflammationInterleukin-12Interleukin-23Interleukin-6LipidsLiverAlanine TransaminaseCcl2 protein, mouseChemokine CCL2Extracellular Signal-Regulated MAP KinasesInterleukin-12Interleukin-23Interleukin-6LipidsNF-kappa BNr4a1 protein, mouseNuclear Receptor Subfamily 4, Group A, Member 1

Identifiers

PMID25307349
PMCPMC4258495
OpenAlexW2052220384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.